Marked increase in anticonvulsant activity but decrease in wet-dog shake behaviour during short-term treatment of amygdala-kindled rats with valproic acid
- PMID: 3138139
- DOI: 10.1016/0014-2999(88)90002-7
Marked increase in anticonvulsant activity but decrease in wet-dog shake behaviour during short-term treatment of amygdala-kindled rats with valproic acid
Abstract
The anticonvulsant activity of valproic acid (VPA) was determined in amygdala-kindled rats after single and repeated (total of 7 injections given 3 times per day) administration of 200 mg/kg i.p. After a single injection, VPA significantly reduced the severity and duration of the kindled seizures and decreased the duration of after-discharges recorded from the stimulated amygdala, but only 12% of the animals were totally protected from seizures. The percentage of animals totally protected increased to 88% after 7 doses. This pronounced increase in the anticonvulsant activity was not related to alterations in the plasma concentrations of VPA or its major active metabolites. Furthermore, determination of VPA and its metabolites in the substantia nigra after a single and repeated administration yielded the same data, again indicating that the increase in the anticonvulsant activity was not due to drug accumulation. In contrast to the marked increase in the anticonvulsant efficacy of VPA during short-term treatment, wet-dog shake behaviour induced by a single injection of the drug was significantly attenuated after repeated dosing, indicating that the anticonvulsant effect of VPA and the wet-dog shake behaviour induced by the drug were not mediated by the same mechanism. This was substantiated by experiments with one of the major metabolites of VPA in rat plasma, trans-2-en-VPA, which had approximately the same anticonvulsant efficacy as VPA but did not induce wet-dog shakes in rats.
Similar articles
-
Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats.Naunyn Schmiedebergs Arch Pharmacol. 1992 Feb;345(2):187-96. doi: 10.1007/BF00165735. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1570023
-
Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.J Pharmacol Exp Ther. 1989 Sep;250(3):1067-78. J Pharmacol Exp Ther. 1989. PMID: 2506334
-
Repeated acute testing of anticonvulsant drugs in amygdala kindled rats: increase in anticonvulsant but decrease in adverse effect potential.Epilepsia. 2000 May;41(5):516-28. doi: 10.1111/j.1528-1157.2000.tb00204.x. Epilepsia. 2000. PMID: 10802756
-
The relationship between plasma concentration of valproic acid and its anticonvulsant and behavioural effects in the rat.Neuropharmacology. 1982 Jun;21(6):555-62. doi: 10.1016/0028-3908(82)90047-8. Neuropharmacology. 1982. PMID: 6810197
-
A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures.Mol Neurobiol. 1996 Aug;13(1):33-60. doi: 10.1007/BF02740751. Mol Neurobiol. 1996. PMID: 8892335 Review.
Cited by
-
Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.Neurochem Res. 1993 Apr;18(4):485-502. doi: 10.1007/BF00967253. Neurochem Res. 1993. PMID: 8097295 Review.
-
Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats.Naunyn Schmiedebergs Arch Pharmacol. 1992 Feb;345(2):187-96. doi: 10.1007/BF00165735. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1570023
-
Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.CNS Drugs. 2002;16(10):669-94. doi: 10.2165/00023210-200216100-00003. CNS Drugs. 2002. PMID: 12269861 Review.
-
Pharmacological, toxicological and neurochemical effects of delta 2(E)-valproate in animals.Pharm Weekbl Sci. 1992 Jun 19;14(3A):139-43. doi: 10.1007/BF01962705. Pharm Weekbl Sci. 1992. PMID: 1502015 Review.
-
Valproate metabolites in the rat brain--regional distribution in various brain areas.Eur J Drug Metab Pharmacokinet. 1999 Jan-Mar;24(1):97-104. doi: 10.1007/BF03190017. Eur J Drug Metab Pharmacokinet. 1999. PMID: 10412898
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials